44.54

0.85% -0.38

After Hours: 44.54

Pulse Biosciences Inc (PLSE)

Overview News Price History Option Chain Financials Discussions Forecast

Pulse Biosciences Inc stock is traded at $44.54, with a volume of 401.11K. It is down -0.85% in the last 24 hours and up +74.94% over the past month. Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.

Previous Close:

$44.92

Open:

$44.5

24h Volume:

401.11K

Relative Volume:

1.05

Market Cap:

$3.18B

Revenue:

$751.00K

Net Income/Loss:

$-74.57M

P/E Ratio:

-40.38

EPS:

-1.1031

Net Cash Flow:

$-55.52M

1W Performance:

+5.02%

1M Performance:

+74.94%

6M Performance:

+93.57%

1Y Performance:

+157.31%

1-Day Range:

$43.75

$45.50

1-Week Range:

$40.68

$46.97

52-Week Range:

$12.56

$46.97

Pulse Biosciences Inc Stock (PLSE) Company Profile

Name

Pulse Biosciences Inc

Sector

Healthcare (1080)

Industry

Medical Instruments & Supplies (56)

Phone

510-906-4600

Address

3957 POINT EDEN WAY, HAYWARD, CA

Employee

116

Twitter

@PulseBioNPS

Next Earnings Date

2026-08-06

Latest SEC Filings

PLSE's Discussions on Twitter

Compare PLSE vs ISRG, BDX, ALC, RMD, MDLN

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PLSE Pulse Biosciences Inc	44.54	3.09B	751.00K	-74.57M	-55.52M	-1.1031
ISRG Intuitive Surgical Inc	394.51	141.76B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	183.40	50.00B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	74.25	35.57B	10.63B	819.00M	1.59B	1.6577
RMD Resmed Inc	224.46	32.78B	5.54B	1.52B	1.74B	10.37
MDLN Medline Inc	35.74	31.15B	29.14B	1.07B	1.05B	1.1956

Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-30-26	Initiated	Mizuho	Outperform
Jul-07-25	Initiated	Oppenheimer	Outperform
Jul-27-21	Initiated	Stephens	Overweight
Mar-11-21	Initiated	Maxim Group	Buy
Jan-26-21	Reiterated	H.C. Wainwright	Buy
May-12-20	Upgrade	H.C. Wainwright	Neutral → Buy
Feb-14-20	Downgrade	H.C. Wainwright	Buy → Neutral
Feb-25-19	Initiated	H.C. Wainwright	Buy

View All

Pulse Biosciences Inc Stock (PLSE) Latest News

Aug 13, 2026

Pulse Biosciences (NASDAQ:PLSE) Sets New 1-Year HighTime to Buy? - MarketBeat

Aug 13, 2026

Pulse Biosciences stock reaches all-time high at 46.03 USD - Investing.com

Aug 13, 2026

Aug 11, 2026

Pulse Biosciences at Canaccord Genuity conference: nsPFA push gains pace By Investing.com - Investing.com Canada

Aug 11, 2026

PLSE: nsPFA technology delivers breakthrough efficacy in AFib and is poised for broad clinical adoption - TradingView

Aug 11, 2026

Aug 10, 2026

PLSE to Join BTIG Virtual Meeting Amid Elevated Price-to-Sales V - GuruFocus

Aug 10, 2026

PLSE Maintains Buy Rating by Canaccord Genuity -- Price Target R - GuruFocus

Aug 10, 2026

Canaccord Genuity Group Issues Positive Forecast for Pulse Biosciences (NASDAQ:PLSE) Stock Price - MarketBeat

Aug 10, 2026

Canaccord raises Pulse Biosciences stock price target on clinical progress - Investing.com India

Aug 10, 2026

Canaccord raises Pulse Biosciences stock price target on clinical progress By Investing.com - Investing.com Canada

Aug 10, 2026

Weekly Recap: Q2 losses, ATM raises and NANOPULSE-AF study past halfway - TradingView

Aug 10, 2026

Pulse Biosciences (PLSE) After NANOPULSE AF Progress As Valuation Questions Build - Sahm

Aug 10, 2026

Aug 08, 2026

Pulse Biosciences (NASDAQ:PLSE) Announces Earnings Results, Misses Estimates By $0.07 EPS - MarketBeat

Aug 08, 2026